Lee Kallenbach
Impact in
- Nephrology top 10%
- Parathyroid Disorders and Treatments
- Dialysis and Renal Disease Management
-
- Air Quality and Health Impacts
- Heavy Metal Exposure and Toxicity
- Mercury impact and mitigation studies
Papers in
-
- Diabetes Treatment and Management 4
- Diabetes Management and Research 3
-
- Metabolism, Diabetes, and Cancer 3
- Co-authors
- Ajay Gupta (1 shared paper)Gerard Zasuwa (1 shared paper)George Divine (1 shared paper)Lawrence J. Fine (2 shared papers)Robert A. Wolfe (2 shared papers)James Melius (2 shared papers)Maureen F. Orr (1 shared paper)Gary D. Langolf (1 shared paper)
- Journals
- International Journal of COPD (2 papers)Value in Health (2 papers)American Journal of Industrial Medicine (1 paper)Therapeutic Innovation & Regulatory Science (1 paper)BMC Endocrine Disorders (1 paper)
- Partner nations
- United StatesSwedenCanada
In The Last Decade
Lee Kallenbach
20 papers receiving 387 citations
Peers
Comparison fields: 5 of 92
- Nephrology 87
- Health, Toxicology and Mutagenesis 166
- Chemical Health and Safety 2
- Endocrinology, Diabetes and Metabolism 45
- Nutrition and Dietetics 38
Countries citing papers authored by Lee Kallenbach
This map shows the geographic impact of Lee Kallenbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Kallenbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Kallenbach more than expected).
Fields of papers citing papers by Lee Kallenbach
This network shows the impact of papers produced by Lee Kallenbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Kallenbach. The network helps show where Lee Kallenbach may publish in the future.
Co-authors
The 25 scholars most cited alongside Lee Kallenbach, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 116 | |
| 2 | 2000 | 95 | |
| 3 | 1996 | 71 | |
| 4 | 1989 | 35 | |
| 5 | 2017 | 15 | |
| 6 | 2020 | 14 | |
| 7 | 2001 | 14 | |
| 8 | 2020 | 6 | |
| 9 | 2021 | 6 | |
| 10 | 2018 | 6 | |
| 11 | 2019 | 6 | |
| 12 | 2020 | 6 | |
| 13 | Effectiveness of a Cloud-Based EHR Clinical Decision Support Program for Body Mass Index (BMI) Screening and Follow-up. | 2017 | 5 |
| 14 | 2018 | 5 | |
| 15 | 2024 | 4 | |
| 16 | 2002 | 4 | |
| 17 | 2018 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2009 | 1 | |
| 20 | 2018 | 1 |
About Lee Kallenbach
Lee Kallenbach is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology, Pulmonary and Respiratory Medicine, Health, Toxicology and Mutagenesis and Surgery, having authored 20 papers that have together received 412 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (4 papers), Diabetes Management and Research (3 papers), Metabolism, Diabetes, and Cancer (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers), Migraine and Headache Studies (2 papers), Mercury impact and mitigation studies (2 papers), Asthma and respiratory diseases (2 papers) and Heavy Metal Exposure and Toxicity (2 papers). The work is most often cited by research in Nephrology (87 citations), Health, Toxicology and Mutagenesis (166 citations), Chemical Health and Safety (2 citations), Endocrinology, Diabetes and Metabolism (45 citations) and Nutrition and Dietetics (38 citations). Lee Kallenbach has collaborated with scholars based in United States, Sweden and Canada. Frequent co-authors include Ajay Gupta, Gerard Zasuwa, George Divine, Lawrence J. Fine, Robert A. Wolfe, James Melius, Maureen F. Orr, Gary D. Langolf, Thomas O. Talbot and James W. Albers. Their work appears in journals such as International Journal of COPD, Value in Health, American Journal of Industrial Medicine, Therapeutic Innovation & Regulatory Science and BMC Endocrine Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.